ICEC0942, an orally bioavailable selective inhibitor of CDK7 for breast cancer

File Description SizeFormat 
10.1007_s10549-016-3898-5.pdfPublished version320.46 kBAdobe PDFView/Open
Title: ICEC0942, an orally bioavailable selective inhibitor of CDK7 for breast cancer
Authors: Ali, S
Patel, H
Periyasamy, M
Bondke, A
Slafer, BW
Ottaviani, S
Harrod, A
Buluwela, L
Fuchter, MJ
Barrett, AGM
Coombes, RC
Item Type: Conference Paper
Issue Date: 20-Aug-2016
Date of Acceptance: 22-Jul-2016
ISSN: 0167-6806
Publisher: Springer Verlag
Start Page: 195
End Page: 195
Journal / Book Title: Breast Cancer Research and Treatment
Volume: 159
Issue: 1
Copyright Statement: © The Author(s) 2016. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (, which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
Sponsor/Funder: Cancer Research UK
Funder's Grant Number: C37/A9335
Conference Name: UK Breast Cancer Research Symposium
Keywords: Science & Technology
Life Sciences & Biomedicine
1112 Oncology And Carcinogenesis
Oncology & Carcinogenesis
Publication Status: Published
Start Date: 2016-07-22
Finish Date: 2016-07-23
Conference Place: London, ENGLAND
Appears in Collections:Division of Surgery
Division of Cancer
Faculty of Medicine
Faculty of Natural Sciences

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Creative Commons